GRT Capital
8195 views
Rate Now: 1 2 3 4

average rating: 3.00 / 1 ratings
DESCRIPTION:

Date updated:04-30-2007

Krochuk and Gregory Fraser, his partner, left Fidelity Investments to launch GRT Capital Partners five and a half years ago. GRT manages $900 million, with $650 million of it invested in its marquee long-short fund. The remaining assets are dispersed over four other investment strategies, including a new Shariah account compliant with Islamic law that started up last month.

Portfolio managers Kim Peters, who heads the Shariah account, and John DeTore, who manages the European market neutral account, chimed in with their top picks in this Barron's 4-30-07 interview.

symbol name last price % change open
  • +
  • LYO
    Lyo
  • $0.00
  • N/A
  • $N/A

Lyondell Chemical (ticker: LYO) is a very cheap stock with lots of free cash flow and an investor friendly management.

People owning LYO also tend to own: BHPBNIOLNPDPFETXNVLO

TheStreet.com Rating: No Rating What is this?

  • +
  • SHLD
    Sears Holdings Co
  • $67.65
  • +1.14%
  • $67.36

Sears Holdings (SHLD) is a way to get exposure to the hedge-fund experience of Eddie Lampert [Edward Lampert is chairman of Sears] without paying hedge-fund fees. He has proven himself to be an excellent manager.

People owning SHLD also tend to own: AAALLAPCBABACCCAT

TheStreet.com Rating: D+ What is this?

  • +
  • AKH
    Akh
  • $0.00
  • N/A
  • $N/A

Air France-KLM (AKH) is a great player in a strong group. It looks inexpensive even though the stock had doubled last year. The reason is that there was a lot of bad news in airlines and the prices were depressed. Bad news in oil prices is already discounted, [and] higher fares and occupancy are still having an impact. Air France is competitive in the industry so the earnings are strong, and looking at the forward fundamentals of the company, we think the stock price could go higher. It sells at 12 times earnings, and analysts are upgrading.

People owning AKH also tend to own: CLFFPLPWEISNEWOSAAUKABC

TheStreet.com Rating: No Rating What is this?

  • +
  • BRK-A
    Berkshire Hath Hl
  • $102400.00
  • +0.49%
  • $101178.00

We don't own a lot of financials in our strategy because they don't work that well quantitatively. [GRT's financial sector exposure is mainly through Berkshire Hathaway, insurers and some savings and loans.

People owning BRK-A also tend to own: COFEBAYHDJNJLINTAOSTKPFE

TheStreet.com Rating: No Rating What is this?

  • +
  • BRK-A
    Berkshire Hath Hl
  • $102400.00
  • +0.49%
  • $101178.00

We don't own a lot of financials in our strategy because they don't work that well quantitatively. [GRT's financial sector exposure is mainly through Berkshire Hathaway, insurers and some savings and loans.

People owning BRK-A also tend to own: COFEBAYHDJNJLINTAOSTKPFE

TheStreet.com Rating: No Rating What is this?

  • +
  • AA
    Alcoa Inc
  • $12.89
  • 0.00%
  • $12.71

Alcoa (AA) and Biogen Idec (BIIB) are cheap on industry-relative forward earnings per share and price-to-book. Alcoa is the leader in alumina production. There's currently little excess world capacity in its markets and the outlook for revenue growth and earnings is very good.

People owning AA also tend to own: AIGIBMINTCJNJJPMKOMSFT

TheStreet.com Rating: C- What is this?

  • +
  • BIIB
    Biogen Idec Inc
  • $45.76
  • +3.09%
  • $44.13

Alcoa (AA) and Biogen Idec (BIIB) are cheap on industry-relative forward earnings per share and price-to-book. Biogen Idec has positive financial momentum, strong historical growth and is highly profitable.

People owning BIIB also tend to own: APOLBRK-BDELLELOSLXKSAFMSGTL

TheStreet.com Rating: B What is this?

  • +
  • ZOLT
    Zoltek Companies
  • $8.67
  • -0.91%
  • $8.63

Short Position: Zoltek (ZOLT) makes carbon fiber. Some of their products are being used in windmill blades. If you accept the fact that carbon fiber is a commodity, the producer is hyped up by alternate energy analysts at over 40 times fiscal 2007 [earnings estimate]. The multiples are too high.

People owning ZOLT also tend to own: APNS.OBAVNRDSCOEBHIECPGEVICGE

TheStreet.com Rating: D+ What is this?

previous next

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...

11.06.09 | 15:52 PM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...

11.05.09 | 12:05 PM
Squeezing the Shorts: Late Earni...

By Jonas Elmerraji Posted on Nov. 4, 2009 For investors who seek out short-squeeze opportunities, there’s no time as important as earnings season. Earnings are one of...

11.04.09 | 15:18 PM
Cramer's Take on Headline Stocks...

By Stockpickr Staff Posted on Nov. 4, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is...

11.04.09 | 11:12 AM
more articles
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
Wealth distribution by race and ...
11.23.08 | 18:44 PM From author Valerie J
Full Disclosure
11.09.08 | 12:30 PM From author alchemist
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
more forums
Q. Pages 78 - 80 of the healthcare ...
11.08.09 | 08:45 AM Asked by Karen Schubeck

A. Type II Diabetes in obese patients is
wrecking our health care system.
Overall, more than $1 in every $10 spent
on health care in the United States goes
toward treating Diabetes. Blood glucose
test strips alone can cost about a
dollar each and if you're testing
several times a day every day, the costs
can add up pretty quickly. XOMA has the
first drug "XOMA 052" in the last 10yrs
which will significantly impact this
industry and you would no longer require
daily insulin injections or insulin at
all, for that matter. This would save
the government billions, search on that
one and you'll make a fortune. The
government cannot continue to pay these
kinds of rising diabetes costs, when
there is an alternative which is so safe
and so effective which just became
patented in Europe.

today 's lists
52-Week Highs

Here are some of the biggest stocks that made the 52-week high list on Nov. 2, 2009. more

Analyst Upgrades

Analyst Upgrades for Nov. 2, 2009. Read more here. more

Biggest % Losers

Here is the stock list of some of the largest % losers from Nov. 2, 2009. more